ADCYAP1 and Parkinson disease: In addition, a recent study by Lamine et al. demonstrated that a synthetic analogue of PACAP, with potential to be developed clinically, showed anti-apoptotic and anti-inflammatory effects both in vitro and in vivo in PD animal models [36].